InvestorsHub Logo
Followers 35
Posts 5257
Boards Moderated 0
Alias Born 10/05/2021

Re: dstock07734 post# 660653

Monday, 01/01/2024 9:46:53 PM

Monday, January 01, 2024 9:46:53 PM

Post# of 711039
Merck is written all over. The Phase 2 UCLA combo trial of 40 patients or so involving Keytruda is the proof. Phase 3 will have a large pool of about 100 patients I expect and Merck will finally stick its neck out taking care of all the expenses plus Les doesn't have to sell C shares no more to keep the lights on... we love to see these changes sooner; can't wait.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News